Abstract
Molecular disease mechanisms typically constitute abnormalities in the regulation of genes producing many kinds of alterations in the expression levels. To identify disease-altered genes better, we have developed an approach that searches for the genes which present a significant rank alteration in the rank of their expression profiles, by comparing an altered rank with another gene. The approach provides groups of genes and assigns a statistical measure of significance to each pair of genes selected. The method is evaluated using two experimental sets of microarrays. We investigated the possibility of inferring the rank reverse pairs and its possibility in diagnostic application when there is no prior knowledge of the genes belonging to disease, nor about the structure of gene regulatory network. We also show that rank reverse is a very powerful technique to diagnostic disease in the practical application and could be used prior to traditional biomarker discovery.
Keywords: Rank reverse, gene expression, diagnostic approach, chip, disease-altered gene
Current Bioinformatics
Title: Microarray Data Analysis to Find Diagnostic Approach and Identify Families of Disease-Altered Genes Based on Rank-Reverse of Gene Expression
Volume: 4 Issue: 3
Author(s): Wenguang Zhang, Jinquan Li, Rui Su and Wu Jianghong
Affiliation:
Keywords: Rank reverse, gene expression, diagnostic approach, chip, disease-altered gene
Abstract: Molecular disease mechanisms typically constitute abnormalities in the regulation of genes producing many kinds of alterations in the expression levels. To identify disease-altered genes better, we have developed an approach that searches for the genes which present a significant rank alteration in the rank of their expression profiles, by comparing an altered rank with another gene. The approach provides groups of genes and assigns a statistical measure of significance to each pair of genes selected. The method is evaluated using two experimental sets of microarrays. We investigated the possibility of inferring the rank reverse pairs and its possibility in diagnostic application when there is no prior knowledge of the genes belonging to disease, nor about the structure of gene regulatory network. We also show that rank reverse is a very powerful technique to diagnostic disease in the practical application and could be used prior to traditional biomarker discovery.
Export Options
About this article
Cite this article as:
Zhang Wenguang, Li Jinquan, Su Rui and Jianghong Wu, Microarray Data Analysis to Find Diagnostic Approach and Identify Families of Disease-Altered Genes Based on Rank-Reverse of Gene Expression, Current Bioinformatics 2009; 4 (3) . https://dx.doi.org/10.2174/157489309789071039
DOI https://dx.doi.org/10.2174/157489309789071039 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Selections
Recent Patents on Biotechnology Mechanisms of Herb-Induced Nephrotoxicity
Current Medicinal Chemistry Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease
Current Molecular Pharmacology Assessing Drug Transport Across the Human Placental Barrier: From In Vivo and In Vitro Measurements to the Ex Vivo Perfusion Method and In silico Techniques
Current Pharmaceutical Biotechnology Erlotinib Hydrochloride Novel Drug Delivery Systems: A Mini Review Unravelling the Role of Micro- and Nanocarriers
Drug Delivery Letters Xenobiotic-Induced Transcriptional Regulation of Xenobiotic Metabolizing Enzymes of the Cytochrome P450 Superfamily in Human Extrahepatic Tissues
Current Drug Metabolism The Potential of PI3K/AKT/mTOR Signaling as a Druggable Target for Endometrial and Ovarian Carcinomas
Current Drug Targets Crosstalk of Long Non-coding RNAs and EMT: Searching the Missing Pieces of an Incomplete Puzzle for Lung Cancer Therapy
Current Cancer Drug Targets Applications of Muscle Electroporation Gene Therapy
Current Gene Therapy Hypoxia Signaling and the Metastatic Phenotype
Current Molecular Medicine Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer
Current Medicinal Chemistry Oncogene Expression Modulation in Cancer Cell Lines by DNA G-Quadruplex-Interactive Small Molecules
Current Medicinal Chemistry Pharmacological Targeting of the Inflamed Intestinal Barrier
Current Pharmaceutical Design Electric cable: cytoskeleton as an electric transmitter for cancer therapy
Current Signal Transduction Therapy Cellular Functions of Vaults and their Involvement in Multidrug Resistance
Current Drug Targets Recent Advances in the Identification of Genetic and Biochemical Components of Breast Cancer Predisposition
Current Genomics Rifaximin: An Antibiotic with Important Biologic Effects
Mini-Reviews in Medicinal Chemistry Regulation of Angiogenesis by Th1- and Th2-Type Cytokines
Current Pharmaceutical Design Delineation of Current Development of Antimitotic Compounds Targeting Cytoskeletal Protein Tubulin and Microtubule in the Cancer Therapy
Current Chemical Biology Cellular Targets and Mechanisms in the Cytotoxic Action of Non-biodegradable Engineered Nanoparticles
Current Drug Metabolism